全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Case-control Studies on the Relationship between Onchocerciasis and Epilepsy: Systematic Review and Meta-analysis

DOI: 10.1371/journal.pntd.0002147

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective A systematic review and meta-analysis of all available case-control studies on the relationship between onchocerciasis and epilepsy. Because age and level of onchocerciasis endemicity in the area of residence are major determinants for infection, an additional analysis was performed, restricted to studies achieving control of these confounding factors. Data sources Medical databases, the “African Neurology Database, Institute of Neuroepidemiology and Tropical Neurology, Limoges,” reference lists of relevant articles, commercial search engines, up to May 2012. Methods We searched for studies examining infection status with Onchocerca volvulus in persons with epilepsy (PWE) and without epilepsy (PWOE) providing data suitable for the calculation of pooled odds ratios (ORp) and/or standardized mean differences (SMD) using random-effects models. Results Eleven studies providing data of qualitative skin biopsies for diagnosis of onchocerciasis were identified. Combined analysis on the total sample of 876 PWE and 4712 PWOE resulted in an ORp of 2.49 (95% confidence interval (95%CI): 1.61–3.86, p<0.001). When this analysis was restricted to those studies achieving control for age, residence and sex (367 PWE, 624 PWOE), an ORp of 1.29 (95% CI: 0.93–1.79; p = 0.139) was found. Presence of nodules for diagnosis of onchocerciasis was analyzed in four studies (225 PWE, 189 PWOE; ORp 1.74; 95%CI: 0.94–3.20; p<0.076), including two studies of the restricted analysis (106 PWE, 106 PWOE; ORp 2.81; 95%CI: 1.57–5.00; p<0.001). One study examined quantitative microfilariae counts in patients without preceding microfilaricidal treatment and demonstrated significantly higher counts in PWE than in PWOE. Interpretation Our results strengthen the hypothesis that, in onchocerciasis foci, epilepsy and infection with O. volvulus are associated. Analysis of indicators giving information on infection intensity, namely nodule palpation and quantitative microfilaria count in untreated patients, support the hypothesis that intensity of infection with O. volvulus is involved in the etiology of epilepsy.

References

[1]  Burnham G (1998) Onchocerciasis. Lancet 351: 1341–1346. doi: 10.1016/S0140-6736(97)12450-3
[2]  Kirkwood B, Smith P, Marshall T, Prost A (1983) Variations in the prevalence and intensity of microfilarial infections by age, sex, place and time in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg 77: 857–861. doi: 10.1016/0035-9203(83)90307-3
[3]  Remme J, Dadzie KY, Karam M (1983) A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 64: 667–681.
[4]  Basá?ez M-G, Boussinesq M (1999) Population biology of human onchocerciasis. Phil Trans R Soc Lond 354: 809–826. doi: 10.1098/rstb.1999.0433
[5]  Basá?ez M-G, Collins RC, Porter CH, Little MP, Brandling-Bennett D (2002) Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am J Trop Med Hyg 67: 669–679.
[6]  Duke BO (1993) The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol 44: 61–68.
[7]  Duerr HP, Raddatz G, Eichner M (2008) Diagnostic value of nodule palpation in onchocerciasis. Trans R Soc Trop Med Hyg 102: 148–154. doi: 10.1016/j.trstmh.2007.10.009
[8]  Duke BO (1962) A standard method of assessing microfilarial densities on onchocerciasis surveys. Bull World Health Organ 40: 629–632.
[9]  Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M (2004) The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol 34: 463–473. doi: 10.1016/j.ijpara.2003.11.008
[10]  Casis-Sacre G (1938) El síndrome epiléptico y sus relaciones con la oncocercosis. Bol Salub Hig (Mexico) 1: 11–31.
[11]  Balanzario I (1942) La oncocercosis y el síndrome epiléptico. Prensa Med Mex 7: 62–64.
[12]  Diaz AF (1963) Sintomatología, diagnóstico y pronóstico. In: Enfermedad de Robles, Universidad de San Carlos de Guatemala, ed. 241–270.
[13]  Kirk R, Morgan HV, Haseeb MA, Satti MH (1959) Onchocerciasis in the Sudan Republic. Ann Trop Med Parasitol 53: 97–102.
[14]  Haseeb MA, Satti MH, Sherif DO (1962) Onchocerciasis in the Sudan. Bull World Health Organ 27: 609–615.
[15]  Duke BO (1998) Onchocerciasis, epilepsy and hyposexual dwarfism. Trans R Soc Trop Med Hyg 92: 236. doi: 10.1016/S0035-9203(98)90763-5
[16]  Pion SD, Kaiser C, Boutros-Toni F, Cournil A, Taylor MM, Meredith SEO, Stufe A, et al. (2009) Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis 3: e461. doi: 10.1371/journal.pntd.0000461
[17]  Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B, Preux P-M (2004) Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology 23: 144–149. doi: 10.1159/000075958
[18]  Kipp W, Kasoro S, Burnham G (1994) Onchocerciasis and epilepsy in Uganda. Lancet 343: 183–184. doi: 10.1016/S0140-6736(94)90980-6
[19]  Ovuga E, Kipp W, Mungherera M, Kasoro S (1992) Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda. East Afr Med J 69: 554–556.
[20]  Kaiser C, Rubaale T, Tukesiga E, Kipp, Kabagambe G, Ojony JO, Asaba G (2011) Association between onchocerciasis and epilepsy in the Itwara hyperendemic focus, West Uganda: Controlling for time and intensity of exposure. Am J Trop Med Hyg 85: 225–228. doi: 10.4269/ajtmh.2011.10-0544
[21]  Moher D, Liberati A, Tetzlaff J, Altman DG (2009) The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analysis: The PRISMA Statement. PLoS Med 6: e1000097. doi: 10.1371/journal.pmed.1000097
[22]  Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, Preux P-M (2010) Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 51: 830–837. doi: 10.1111/j.1528-1167.2009.02401.x
[23]  Hardy RJ, Thompson SG (1996) A likelihood approach to meta-analysis with random effects. Stat Med 15: 619–629. doi: 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A
[24]  Normand S-L (1999) Meta-analysis: formulating, evaluating, combining and reporting. Statistics in Medicine 18: 321–359. doi: 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P
[25]  Deeks JJ, Altman DG, Bradburn MJ (2008) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG. Reviews in health care: Meta-analysis in context, 2nd edition, London: BMJ Publishing Group. pp. 248–282
[26]  Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Steichen T (2006) “METAN: Stata module for fixed and random effects meta-analysis”, statistical software components S456798, revised 23 Sep 2010. Boston (Massachusetts): Boston College Department of Economics. Available: http://ideas.repec.org/c/boc/bocode/s456?798.html. Accessed 24 February 2013
[27]  Prost A, Hervouet JP, Thylefors B (1979) Les niveaux d'endémicité dans l'onchocercose. Bull World Health Organ 57: 655–662.
[28]  Ngoumou P, Walsh JF (1993) A manual for Rapid Epidemiological Mapping of Onchocerciasis. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases and WHO Programme for the Prevention of Blindness. TDR/TDE/ONCHO/93.4.
[29]  Boussinesq M, Pion SD, Ngangue Demanga, Kamgno J (2002) Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. Trans R Soc Trop Med Hyg 96: 537–541. doi: 10.1016/S0035-9203(02)90433-5
[30]  Druet-Cabanac M, Preux PM, Bouteille B, Bernet-Bernady, Dunand J, et al. (1999) Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic. Am J Epidemiol 149: 565–570. doi: 10.1093/oxfordjournals.aje.a009853
[31]  Farnarier G, Diop S, Coulibaly B, Arborio A, Dabo A, et al. (2000) Onchocercose et épilepsie. Enquête épidémiologique au Mali. Med Trop (Mars) 60: 151–155.
[32]  Gbenou HD (1995) Contribution à l'étude de l'association onchocercose-épilepsie. Résultats préliminaires d'une enquête neuroépidemiologique à Agbogbome, Commune de Paouignan, Sous-Préfecture de Dassa-Zoumé, au Bénin. MD Thesis, National University of Benin. 126 pp.
[33]  Kaboré JK, Cabore JW, Melaku Z, Druet-Cabanac M, Preux PM (1996) Epilepsy in a focus of onchocerciasis in Burkina Faso. Lancet 347: 836. doi: 10.1016/S0140-6736(96)90917-4
[34]  Kaboré J, Preux PM, Kabre D (2000) Prévalence de l'épilepsie dans le bassin de la Bougouriba. Bull Soc Pathol Exot 93: 267–268.
[35]  Kabré D (1998) épidémiologie de l'épilepsie dans le foyer d'onchocercose du bassin de la Bougouriba (Burkina Faso). MD Thesis: University of Ouagadougou. 62 pp.
[36]  K?nig R, Nassri A, Meindl M, Matuja W, Kidunda AR, et al. (2010) The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania. Parasitology 137: 1559–1568. doi: 10.1017/S0031182010000338
[37]  K?nig R, Nassri A, Meindl M, Kidunda A, Matuja W et al.. (2006) Epilepsie und Onchozerkose in Mahenge, Tansania [Abstract]. In: Proceedings of the 40. Jahrestagung der ?sterreichischen Gesellschaft für Tropenmedizin und Parasitologie, p.22; November 2–4 2006; Linz, Austria. Available: http://oe002rz5.edis.at/fileadmin/public?/Jahrestagungen/abstracts_linz_2006.pdf. Accessed 24 February 2013.
[38]  Newell ED, Vyungimana F, Bradley JE (1997) Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. Trans R Soc Trop Med Hyg 91: 525–527. doi: 10.1016/S0035-9203(97)90009-2
[39]  Pion SD, Boussinesq M (2012) Significant association between epilepsy and presence of onchocercal nodules: case-control study in Cameroon. Am J Trop Med Hyg 86: 557. doi: 10.4269/ajtmh.2012.11-0603a
[40]  Prischich F, De Rinaldis M, Bruno F, Egeo G, Santoro C, et al. High prevalence of epilepsy in a village in the Littoral Province of Cameroon. Epilepsy Res 82: 200–210. doi: 10.1016/j.eplepsyres.2008.09.004
[41]  Taylor MM, Meredith SE, Stufe A (1999) The prevalence of epilepsy in an area hyperendemic for onchocerciasis in Tanzania. Am J Trop Med Hyg 61: 321.
[42]  Vaz T (1999) Facteurs de risque de l'épilepsie au Mali à propos d'une enquête en zone d'endémie onchocerquienne. MD Thesis: University of Aix-Marseille II. 217 pp.
[43]  Tume BT, Fatcheu CD, Tiodjio ER, Dongmo, Ateufack G, et al. (2012) Purification and characterization of circulating Onchocerca volvulus antigens from epileptic and non-epileptic onchocerciasis patient sera. Int J Biol Chem Sci 6: 289–297. doi: 10.4314/ijbcs.v6i1.25
[44]  K?hler M (2009) Onchozerkose und Epilepsie – Eine Fallkontrollstudie in der l?ndlichen Region Sanaga-Maritime in Kamerun. MD Thesis: University of Würzburg, Germany. pp. 118.
[45]  Schmutzhard E, Koenig R, Nassri A, Meindl M, Kidunda A, et al.. (2008) The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania [Abstract P06.183]. In: Proceedings of the American Academy of Neurology 60th annual meeting; 12–19 April 2008; Chicago, Illinois, United States. Available: http://www.aan.com/globals/axon/assets/3?706.pdf. Accessed 24 February 2013.
[46]  Anderson J, Fuglsang H, Hamilton PJ, de Marshall TF (1974) Studies on onchocerciasis in the United Cameroon Republic. I. Comparison of populations with and without Onchocerca volvulus. Trans R Soc Trop Med Hyg 68: 190–208. doi: 10.1016/0035-9203(74)90116-3
[47]  Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, et al. (2003) Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West Africa. Filaria J 2: e8.
[48]  Kennedy MH, Bertocchi I, Hopkins AD, Meredith SE (2002) The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Ann Trop Med Parasitol 96: 297–307. doi: 10.1179/000349802125000736
[49]  Kaiser C, Asaba G, Leichsenring M, Kabagambe G (1998) High incidence of epilepsy related to onchocerciasis in West Uganda. Epilepsy Res 30: 247–51. doi: 10.1016/S0920-1211(98)00007-2
[50]  Rwiza HT, Kilonzo GP, Haule J, Matuja WB, Mteza I, et al. (1992) Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: A community-based study. Epilepsia 33: 1051–1056. doi: 10.1111/j.1528-1157.1992.tb01758.x
[51]  Kaiser C, Kipp W, Asaba G, Mugisa C, Kabagambe G, et al. (1996) The prevalence of epilepsy follows the distribution of onchocerciasis in a West Ugandan focus. Bull World Health Organ 74: 361–367.
[52]  Osuntokun BO, Adeuja AO, Nottidge VA, Bademosi O, Olumide A, et al. (1987) Prevalence of epilepsies in Nigerian Africans: A community based study. Epilepsia 28: 272–279. doi: 10.1111/j.1528-1157.1987.tb04218.x
[53]  Birbeck GL, Kalichi EM (2004) Epilepsy prevalence in rural Zambia: a door-to-door survey. Trop Med Int Health 9: 92–95. doi: 10.1046/j.1365-3156.2003.01149.x
[54]  Raper AB, Ladkin RG (1950) Endemic dwarfism in Uganda. East Afr Med J 27: 339–359.
[55]  Kipp W, Burnham G, Bamuhiga J, Leichsenring M (1996) The Nakalanga syndrome in Kabarole district, western. Uganda 54: 80–83.
[56]  Kaiser C, Asaba G, Kasoro S, Rubaale T, Kabagambe G, et al. (2007) Mortality from epilepsy in an onchocerciasis-endemic area in West Uganda. Trans R Soc Trop Med Hyg 101: 48–55. doi: 10.1016/j.trstmh.2006.06.003
[57]  Jilek-Aall L, Jilek W, Miller JR (1979) Clinical and genetic aspects of seizure disorders prevalent in an isolated African population. Epilepsia 20: 613–622. doi: 10.1111/j.1528-1157.1979.tb04845.x
[58]  Kaiser C, Benninger C, Asaba G, Mugisa C, Kabagambe G, et al. (2000) Clinical and electro-clinical classification of epileptic seizures in West Uganda. Bull Soc Pathol Exot 93: 255–259.
[59]  Lacey M (2003) Nodding disease: Mystery of Southern Sudan. Lancet Neurol 2: 714. doi: 10.1016/S1474-4422(03)00599-4
[60]  Winkler AS, Friedrich K, K?nig R, Meindl M, Helbok R, et al. (2008) The head nodding syndrome – Clinical classification and possible causes. Epilepsia 49: 2008–2015. doi: 10.1111/j.1528-1167.2008.01671.x
[61]  Sejvar JJ, Kakooza AM, Foltz JI, Makumbi I, Atai-Omoruto AD, et al. (2013) Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: an observational case series. Lancet Neurol in press (published online January 8, 2013).
[62]  Centers for Disease Control and Prevention (2012) Nodding syndrome - South Sudan, 2011. Morb Mortal Wkly Rep 61: 52–54.
[63]  Kaiser C, Asaba G, Mugisa C, Kipp W, Kasoro S, et al. (1998) Antiepileptic drug treatment in rural Africa: involving the community. Trop Doc 28: 73–77.
[64]  Preux PM, Druet-Cabanac M (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21–31. doi: 10.1016/S1474-4422(04)00963-9
[65]  Newton CR, Garcia HH (2012) Epilepsy in poor regions of the world. Lancet 380: 1193–1201. doi: 10.1016/S0140-6736(12)61381-6
[66]  Katabarwa M, Lakwo T, Habumogisha P, Richards F, Eberhard M (2008) Could neurocystocercosis be the cause of “onchocerciasis-associated” epileptic seizures? Am J Trop Med Hyg 78: 400–401.
[67]  Dumas M, Grunitzky K, Belo M, Dabis F, Deniau M, et al. (1990) Cysticercose et neurocysticercose: enquête épidémiologique dans le nord du Togo. Bull Soc Pathol Exot 83: 263–274.
[68]  Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, et al. (2003) Cysticercosis as a major risk factor for epilepsy in Burundi, East Africa. Epilepsia 44: 950–955. doi: 10.1046/j.1528-1157.2003.55302.x
[69]  Kaiser C, Pion S, Preux PM, Kipp W, Dozie I, Boussinesq M (2008) Onchocerciasis, cysticercosis, and epilepsy. Am J Trop Med Hyg 79: 643–645.
[70]  Goudsmit J, van der Waals FW, Gajdusek DC (1983) Epilepsy in the Gbawein and Wroughbarh clan of Grand Bassa county, Liberia: The occurrence of ‘See-ee’ in the native population. Neuroepidemiology 2: 24–34.
[71]  Van der Waals FW, Asher DM, Goudsmit J, Pomeroy KL, Karabatsos N, Gajdusek DC (1986) Post-encephalitic epilepsy and arbovirus infections in an isolated rainforest area of central Liberia. Trop Geogr Med 38: 203–208.
[72]  Ollivier G, Boussinesq M, Albaret JL, Cumberlidge N, Farhati K, et al. (1995) Etude épidémiologique d'une distomatose à Paragonimus sp. au Sud-Cameroun. Bull Soc Pathol Exot 88: 164–169.
[73]  Mazzotti L (1959) Presencia de microfilarias de Onchocerca volvulus en el liquido cefalorraquideo de enfermos tratados con hetrazan. Rev Inst Salubr Enferm Trop (Mex) 19: 1–5.
[74]  Duke BO, Vincelette J, Moore PJ (1976) Microfilariae in the cerebral fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed Parasitol 27: 123–32.
[75]  Duke BO, Moore PJ, Vincelette J (1976) The population dynamics of Onchocerca volvulus microfilariae during treatment with suramin and diethylcarbamazine. Tropenmed Parasitol 27: 133–144.
[76]  Kaiser C, Pion S, Boussinesq M (2009) Head nodding syndrome and river blindness: a parasitological perspective. Epilepsia 50: 2325–2326. doi: 10.1111/j.1528-1167.2009.02280.x
[77]  Mira MG (1934) Sulla presenza delle microfilarie di ‘Onchocerca coecutiens Brumpt’ nel nervo ottico. Riforma Medica 50: 858–861.
[78]  Hughes MH, Daly PJ (1950) Ocular onchocerciasis. Trans R Soc Trop Med Hyg 43: 362.
[79]  Rodger FC (1958) Posterior degenerative lesion of onchocerciasis. Br J Ophthalmol 42: 21–37. doi: 10.1136/bjo.42.1.21
[80]  Rodger FC (1959) The movement of microfilariae of Onchocerca volvulus in the human eye from lid to retina. Trans R Soc Trop Med Hyg 53: 138–141. doi: 10.1016/0035-9203(59)90062-8
[81]  Paul EV, Zimmerman LE (1970) Some observations on the ocular pathology of onchocerciasis. Hum Pathol 1: 581–594. doi: 10.1016/S0046-8177(70)80058-2
[82]  McKechnie NM, Braun G, Connor V, Kl?ger S, Taylor DW, et al. (1993) Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis. Invest Ophthalmol Vis Sci 34: 2888–2902.
[83]  Marin B, Boussinesq M, Druet-Cabanac M, Kamgno J, Bouteille B, et al. (2006) Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 22: 17–20. doi: 10.1016/j.pt.2005.11.006
[84]  Pezzani R, Mucignat C, Giometto B, Caldrer S, Quarello A, et al.. (2006) Analysis with immunohistochemistry and western blot of children affected by nodding syndrome [Abstract A239.16]. In: Proceedings of the 5th Forum of European Neuroscience; 8–12 July 2006; Vienna, Austria. Available: http://fens2006.neurosciences.asso.fr/ab?stracts/R7/A239_16.html. Accessed 24 February 2013.
[85]  Owolabi MO, Bower JH, Adesola Ogunniyi A (2007) Mapping Africa's way into prominence in the field of neurology. Arch Neurol 64: 1696–1700. doi: 10.1001/archneur.64.12.1696

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133